Metis Global Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Metis Global Partners, LLC

$3.79 Billion
Q2 2025

A detailed history of Metis Global Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Metis Global Partners, LLC holds 14,118 shares of VRTX stock, worth $5.47 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

14,118

Previous 15,699 10.07%

Holding current value

$5.47 Million

Previous $7.61 Million 17.42%

% of portfolio

0.17%

Previous 0.22%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 06, 2025	SELL	$421.16 - $509.5 $665,853 - $805,519	-1,581 Reduced 10.07%	14,118 $6.29 Million
Q1 2025 May 07, 2025	BUY	$402.49 - $513.76 $730,116 - $931,960	1,814 Added 13.06%	15,699 $7.61 Million
Q4 2024 Feb 05, 2025	BUY	$396.64 - $516.74 $170,555 - $222,198	430 Added 3.2%	13,885 $5.59 Million
Q3 2024 Nov 06, 2024	BUY	$460.0 - $505.78 $463,220 - $509,320	1,007 Added 8.09%	13,455 $6.26 Million
Q2 2024 Aug 06, 2024	SELL	$392.81 - $485.53 $24,747 - $30,588	-63 Reduced 0.5%	12,448 $5.83 Million
Q1 2024 May 06, 2024	BUY	$407.69 - $446.08 $29,353 - $32,117	72 Added 0.58%	12,511 $5.23 Million
Q4 2023 Feb 06, 2024	SELL	$343.0 - $410.68 $162,925 - $195,073	-475 Reduced 3.68%	12,439 $5.06 Million
Q3 2023 Nov 07, 2023	BUY	$338.18 - $362.46 $477,171 - $511,431	1,411 Added 12.27%	12,914 $4.49 Million
Q2 2023 Aug 07, 2023	SELL	$314.42 - $351.91 $3,773 - $4,222	-12 Reduced 0.1%	11,503 $4.05 Million
Q1 2023 May 08, 2023	BUY	$283.23 - $323.1 $654,544 - $746,684	2,311 Added 25.11%	11,515 $3.63 Million
Q4 2022 Feb 07, 2023	BUY	$285.76 - $321.48 $879,569 - $989,515	3,078 Added 50.24%	9,204 $2.66 Million
Q3 2022 Nov 08, 2022	BUY	$273.83 - $305.53 $96,114 - $107,241	351 Added 6.08%	6,126 $1.77 Million
Q2 2022 Aug 08, 2022	BUY	$234.96 - $292.55 $412,824 - $514,010	1,757 Added 43.73%	5,775 $1.63 Million
Q1 2022 May 03, 2022	BUY	$221.42 - $260.97 $388,813 - $458,263	1,756 Added 77.63%	4,018 $1.05 Million
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $400,396 - $505,443	2,262 New	2,262 $497,000

Others Institutions Holding VRTX

# of Institutions

1,810

Shares Held

232M

Call Options Held

1.51M

Put Options Held

1.08M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $99.5B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Metis Global Partners, LLC with notifications on news.

Account

Metis Global Partners, LLC Vertex Pharmaceuticals Inc Transaction History